What Biotech CEOs (and Their Funders) Learned From the Theranos Debacle


Biotech investors are still stunned by the rise and fall of the one-drop blood testing startup. But they’re hellbent on making sure they don’t all get burned again.

from Feed: All Latest http://ift.tt/2tYTgWT
via techgadgettalk.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s